Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine

被引:160
作者
Bieber, Th. [1 ]
机构
[1] Univ Bonn, Dept Dermatol & Allergy, D-53105 Bonn, Germany
关键词
asthma; atopic dermatitis; atopic march; disease modification; personalized medicine; FC-EPSILON-RI; GENOME-WIDE ASSOCIATION; ACTIVATION-REGULATED CHEMOKINE; HIGH-AFFINITY RECEPTOR; OF-FUNCTION MUTATION; TOLL-LIKE RECEPTOR-2; ALPHA-CHAIN GENE; SERUM IGE LEVELS; FILAGGRIN MUTATIONS; PROMOTER REGION;
D O I
10.1111/all.12049
中图分类号
R392 [医学免疫学];
学科分类号
100108 [医学免疫学];
摘要
Atopic dermatitis (AD) is a paradigmatic inflammatory chronic skin disease. As for other chronic skin diseases, (i) the spectrum of the clinical phenotype and severity as well as (ii) the genetic background and (iii) the underlying mechanisms strongly suggest a high degree of pathophysiological heterogeneity yet leading to a similar clinical pattern, that is, the eczematous skin lesion, but showing distinct progression patterns. This review suggests to exploit the recent knowledge about AD for a novel approach proposing a tentative first molecular taxonomy of this disease based on the genotype and endophenotype. The consequences in terms of personalized prevention and management are delineated.
引用
收藏
页码:1475 / 1482
页数:8
相关论文
共 122 条
[1]
The Toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype [J].
Ahmad-Nejad, P ;
Mrabet-Dahbi, S ;
Breuer, K ;
Klotz, M ;
Werfel, T ;
Herz, U ;
Heeg, K ;
Neumaier, M ;
Renz, H .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2004, 113 (03) :565-567
[2]
Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood:: ISAAC Phases One and Three repeat multicountry cross-sectional surveys [J].
Asher, M. Innes ;
Montefort, Stephen ;
Bjorksten, Bengt ;
Lai, Christopher K. W. ;
Strachan, David P. ;
Weiland, Stephan K. ;
Williams, Hywel .
LANCET, 2006, 368 (9537) :733-743
[3]
Bannister M J, 2000, Australas J Dermatol, V41, P225
[4]
An update on the genetics of atopic dermatitis: Scratching the surface in 2009 [J].
Barnes, Kathleen C. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2010, 125 (01) :16-29
[5]
Barnetson RC, 1993, ALLERGY, P28
[6]
The role of vitamin D in the immunopathogenesis of allergic skin diseases [J].
Benson, A. A. ;
Toh, J. A. ;
Vernon, N. ;
Jariwala, S. P. .
ALLERGY, 2012, 67 (03) :296-301
[7]
IGE CONCENTRATIONS IN CHILDREN WITH ATOPIC DISEASES - A CLINICAL STUDY [J].
BERG, T ;
JOHANSSO.SG .
INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1969, 36 (03) :219-&
[8]
Atopic dermatitis: a candidate for disease-modifying strategy [J].
Bieber, T. ;
Cork, M. ;
Reitamo, S. .
ALLERGY, 2012, 67 (08) :969-975
[9]
HUMAN EPIDERMAL LANGERHANS CELLS EXPRESS THE HIGH-AFFINITY RECEPTOR FOR IMMUNOGLOBULIN-E (FC-EPSILON-RI) [J].
BIEBER, T ;
DELASALLE, H ;
WOLLENBERG, A ;
HAKIMI, J ;
CHIZZONITE, R ;
RING, J ;
HANAU, D ;
DELASALLE, C .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 175 (05) :1285-1290
[10]
Bieber T., 2012, DERMATOLOGY, P203